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Abstract
Background: Cigarette smoking is a known cause of cancer, and cancer may be in part due to effects of oxidative
stress. However, whether smoking cessation reverses oxidatively induced DNA damage unclear. The current study
sought to examine the extent to which three DNA lesions showed significant reductions after participants quit
smoking.
Methods: Participants (n = 19) in this study were recruited from an ongoing 16-week smoking cessation clinical
trial and provided blood samples from which leukocyte DNA was extracted and assessed for 3 DNA lesions
(thymine glycol modification [d(T
gpA)]; formamide breakdown of pyrimidine bases [d(T
gpA)]; 8-oxo-7,8-
dihydroguanine [d(G
h)]) via liquid chromatography tandem mass spectrometry (LC-MS/MS). Change in lesions over
time was assessed using generalized estimating equations, controlling for gender, age, and treatment condition.
Results: Overall time effects for the d(T
gpA) (c
2(3) = 8.068, p < 0.045), d(P
fpA) (c
2(3) = 8.477, p < 0.037), and d(G
h)
(c
2(3) = 37.599, p < 0.001) lesions were seen, indicating levels of each decreased significantly after CO-confirmed
smoking cessation. The d(T
gpA) and d(P
fpA) lesions show relatively greater rebound at Week 16 compared to the d
(G
h) lesion (88% of baseline for d(T
gpA), 64% of baseline for d(P
fpA), vs 46% of baseline for d(G
h)).
Conclusions: Overall, results from this analysis suggest that cigarette smoking contributes to oxidatively induced
DNA damage, and that smoking cessation appears to reduce levels of specific damage markers between 30-50
percent in the short term. Future research may shed light on the broader array of oxidative damage influenced by
smoking and over longer durations of abstinence, to provide further insights into mechanisms underlying
carcinogenesis.
Introduction
A commonality in the etiology of cancers may be DNA
damage arising from oxidative stress [1,2]. There are
multiple reasons to associate oxidative stress with can-
cer. Oxidative DNA damage can cause transcription
errors, replication errors, and genomic instability, which
are all associated with carcinogenesis [3-7]. Over 100
oxidative DNA damage products are known, and reac-
tive oxygen species (ROS) can induce DNA breaks, pur-
ine, pyrimidine, or deoxyribose lesions, and even cross
links among these [5].
Oxidative stress in cells and organisms is caused by
the presence of ROS, including hydroxyl radicals,
superperoxide, hydrogen peroxide, and singlet oxygen.
Cells or organisms having an inordinately high level of
ROS are said to be under oxidative stress. ROS are gen-
erated inadvertently in the mitochondria of all cells con-
comitant with the synthesis of ATP. ROS arise due to
oxygen that escapes complete reduction. Other in-vivo
sources of ROS include inflammatory responses and
detoxification processes. Cigarette smoking is an impor-
tant cause of cancer [8] and it is well established that
tobacco smoke contains thousands of chemicals and
causes inflammation. It is also known that ROS are gen-
erated during the combustion of tobacco products
[9-11]. Cancer risk associated with oxidative stress may
be explained in that ROS can cause oxidative DNA
damage that lead to mutations that lead to cancer.
The connection between environmental exposures like
cigarette smoking and cancer may be better understood
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cinogenic process. Prior work in examining environmen-
tal sources of oxidative damage has generally focused on
the 8-oxo-7,8-dihydroguanine [d(G
h)] lesion. Findings
on cigarette smoke exposure have been decidedly mixed
[10]. Priemé and colleagues [12] reported a decrease of
about 20% in d(G
h) among those quitting smoking up
to 26 weeks. Lodovici et al., [13] as well as Asami et al.,
[14] reported a significantly lower mean value of d(G
h)
in leukocyte DNA of non-smokers compared with smo-
kers while Nia et al., [15] and Van Zeeland et al. [16]
reported a lower average value for d(G
h) in lymphocyte
DNA of smokers compared with non-smokers. Lodovici
et al., [13] also demonstrated that d(G
h) was elevated in
those exposed to secondhand smoke, similar to an ear-
lier finding by Howard et al. [17] showing elevated levels
in those occupationally exposed to SHS. However, Coll-
ier and colleagues [18] have shown that men and
women differed in their oxidative damage levels due to
SHS exposure, with a more prominent dose-response
effect seen in men.
An issue with the existing literature is the reliance on
the d(G
h) lesion as the primary indicator of oxidatively-
induced DNA damage from cigarette smoking. This
base modification is not a significant product of deoxy-
guanosine exposed in vitro to hydroxyl radicals [19]. In
addition, the facile oxidation of guanine leads to artifac-
tual production of d(G
h). A preferable approach may be
to examine base modifications that unequivocally can be
associated with hydroxyl radical activity. Modern mass
spectrometry now makes it feasible to measure the
levels of multiple oxidatively-induced DNA lesions
simultaneously. Two such alternative base modifications
are a) the glycol modification of thymine [d(T
gpA)], and
b) the formamide breakdown product of pyrimidine
bases [d(P
fpA)]. The structures of these modifications
are shown in Figure 1 in the form they are measured.
Included in Figure 1 is the structure of d(G
h), the DNA
modification most often used as an indicator of oxida-
tive stress.
T h ec u r r e n ts t u d ys o u g h tt oe x a m i n et h ee x t e n tt o
which these three DNA lesions would show measurable
change upon cessation of smoking in a longitudinal
fashion. Our study is notable in two respects: longitudi-
nal measurements were a component of an on-going
smoking cessation study and study subjects served as
their own controls.
Methods
Experimental Procedures
Participants (n = 19) in this study were recruited from
an ongoing 16-week smoking cessation clinical trial
using varenicline. Criteria for inclusion were smoking at
least 15 cigarettes per day, general good health, and will-
ingness to make a quit attempt. Persons were excluded
if they currently used tobacco products other than cigar-
ettes; were using smoking cessation drugs at time of
enrollment (e.g., varenicline, bupropion, nicotine); had a
serious medical or mental health condition in the past
year; abused alcohol or other drugs; or were pregnant or
planning to become pregnant. Eligible participants
received either medication (varenicline) or a placebo as
part of a double-blind cessation study. Both self-
reported tobacco use and measured breath carbon mon-
oxide (CO) levels were used to determine tobacco use
status at each visit. Blood samples were obtained from
volunteer donors at baseline (4 weeks prior to target
quit ), on the target quit date (Study Week 0), 4 weeks
following target quit date (Study Week 4), and 11 weeks
after target quit date (Study Week 11). (see Figure 2)
Participants received $25 remuneration for each blood
sample provided. The study protocol was reviewed and
approved by the Roswell Park Cancer Institute Institu-
tional Review Board. All participants provided written
Figure 1 DNA dimer modifications under investigation.
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an optional component of the clinical trial.
Analytical Procedures
Blood samples were drawn with EDTA as anticoagulant,
centrifuged, and the buffy coat collected. DNA was
extracted from the cells using a kit designed to mini-
mize spurious oxidation reactions (ZeptoMetrix, Inc.,
Buffalo, NY). The kit employs chaotropic precipitation
of the DNA together with desferol in the extraction pro-
cedure. One hundred μgo fD N Aw a sh y d r o l y z e da n d
dephosphorylated using nuclease P1 and alkaline phos-
phatase. A solution containing 15 μl sodium acetate buf-
fer (0.25 M, pH 5.2), 50 μl3 . 0m MZ nC l 2,5 0μLw a t e r
and 1.0 U nuclease P1 (Sigma N8630) together with the
DNA and isotopically labeled internal standards was
incubated at 37°C for 2 h at pH 5.2. After addition of 25
μl of Tris-HCl (1 M, pH 9.0) and 70 U of alkaline phos-
phatase, the sample was incubated for an additional 2 h
at pH 8.2. Samples were analyzed using liquid chroma-
tography tandem mass spectrometry (LC-MS/MS). The
methodology and internal standards used for measuring
oxidative DNA damage at the dimer level have been
described previously [20-23].
Since the use of the d(P
fpA) and d(T
gpA) base modifi-
cations as measures of oxidatively generated DNA
damage is relatively new, we examined repeatability of
these measurements. Pairs of samples from the same
participant were prepared and analyzed in parallel. The
average values for the two set differed by 6% for the d
(T
gpA) modification (12 pairs; r = 0.89) and 5% for the
d(P
fpA) modification (36 pairs; r = 0.74).
Data analysis
To assure a ‘clean’ sample for assessment of cessation
effects on levels of oxidative damage, analyses were
Figure 2 Study timeline.
Table 1 Demographic and smoking behavior characteristics of the sample and interrelationships among measures at
baseline
t-statistic and p-value for comparison on demographic variables
N (%) Cigs CO d(T
gpA) d(P
fpA) dG
h
Gender Male 10 (52%) t 1.187 2.205 -0.409 -0.318 -0.580
Female 9 (48%) p 0.251 0.041 0.688 0.755 0.569
Race White 15 (79%) t 1.259 0.434 -0.849 -0.647 1.145
Black 4 (21%) p 0.225 0.670 0.408 0.526 0.268
Treatment Group Active 13 (68%) t -0.577 0.109 -0.163 0.845 1.688
Placebo 6 (32%) p 0.571 0.914 0.873 0.410 0.110
Mean (SD) Pearson correlation and p-value between biomarkers and smoking variables
Age (years) 50.2 (10.1) r -0.12 0.31 -0.03 -0.10 -0.35
p 0.630 0.199 0.889 0.680 0.146
Years Smoked 28.8 (9.6) r 0.22 0.40 0.04 0.01 -0.14
p 0.358 0.090 0.861 0.972 0.573
Cigarettes per Week 126 (33) r 1.00 0.56 -0.09 -0.18 0.04
p – 0.013 0.706 0.474 0.881
Carbon Monoxide (ppm) 40.9 (3.7) r 0.56 1.00 -0.29 -0.22 -0.05
p 0.013 – 0.225 0.357 0.848
Statistically significant effects noted in boldface.
Cigs = Cigarettes smoked per week (N)
CO = Carbon monoxide (ppm)
d(T
gpA) = glycol modification of thymine (fmol/μg)
d(P
fpA) = formamide breakdown product of pyrimidine bases (fmol/μg)
d(G
h) = 8-oxo-7,8-dihydroguanine (fmol/μg)
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demonstrated CO-confirmed abstinence at 4 weeks and
11 weeks after TQD. The initial approach to analysis
was descriptive (Pearson correlations, cross tabulations,
t-tests) and focused on patient demographics and base
m o d i f i c a t i o n sa c r o s ss u b j e c t sa n dw e e k s .G e n e r a l i z e d
estimating equations (GEE) were employed to examine
the significance of change in biomarkers across time,
accounting for the within-subjects dependence of mea-
surements and adjusting for gender, treatment group
(Active, Placebo) and age [24]. The GEE models used a
normal distribution with log link function, and an
exchangeable working correlation matrix for the
repeated measurement. Analyses were conduced using
SPSS 16.0 (SPSS Inc., Chicago, IL).
Results
Demographic and tobacco use history data among parti-
cipants are summarized in Table 1. We examined base-
line values for cigarette consumption, exhaled CO, and
the three DNA lesions measured as a function of parti-
cipant demographics. We observed higher baseline
exhaled breath CO levels among male compared to
female participants (48.0 ppm (SEM 5.1) vs. 33.1 ppm
(SEM 4.3)), and also noted a significant correlation
between cigarettes smoked per week and CO levels. At
baseline there was no significant relationship among
these metrics and the three DNA lesions of interest.
The results of measurements of d(T
gpA), d(P
fpA), and
d(G
h) modifications are presented in Table 2 for each of
the four time points. The mean values of the measure-
ments and SEM’s are given in terms of femtomoles
(fmol) of lesions per microgram (μg) of DNA. Figure 3
illustrates the interindividual variability in measurements
at each timepoint as well as changes across time. An
overall pattern was apparent for all 3 markers demon-
strating decreases over time coinciding with stopping
smoking. Two biomarkers (d(T
gpA) and d(P
fpA))
increased on average at the final measurement. Results
of generalized estimating equation analysis (accounting
Table 2 Geometric mean thymine glycol (d(T
gpA)), formamide (d(P
fpA)) and 8-oxo-7,8-dihydroguanine (dG
h) lesions
(fmol/μg) by week, unadjusted and adjusted for age, gender, and treatment condition
Sample (N) % abstinent Cigarette per week (SEM) d(T
gpA) fmol/μg
(SEM)
d(P
fpA) fmol/μg
(SEM)
dG
h fmol/μg (SEM)
Unadj Adj Unadj Adj Unadj Adj
TQD - 4 weeks [baseline]
(N = 19)
0 126 (7.5) 0.89 (1.15) 1.06 (0.15) 1.77 (1.13) 1.93 (0.20) 31.70 (1.12) 33.15 (2.49)
TQD [week 0] (N = 19) 68.4 85 (8.7) 0.55 (1.19) 0.71 (0.10) 1.51 (1.09) 1.55 (0.12) 21.97 (1.07) 21.48 (1.68)
TQD + 4 weeks [week 4]
(N = 13)
100 0 0.57 (1.17) 0.64 (0.09) 1.07 (1.14) 1.12 (0.17) 16.40 (1.11) 15.76 (1.65)
TQD +11 [week 11] (N = 10) 100 0 0.81 (1.18) 0.91 (0.13) 1.25 (1.13) 1.23 (0.14) 15.56 (1.15) 15.43 (2.60)
NOTE: Abstinence defined by exhaled breath CO ≤ 8 ppm. Adjusted means are from GEE model including only those cases reporting no cigarettes smoked in the
past week and showing CO-confirmed abstinence and controlling for treatment condition, gender, and age. TQD, target quit date.
Figure 3 Individual patterns of change in lesion levels by study
week.
Box et al. Tobacco Induced Diseases 2011, 9:5
http://www.tobaccoinduceddiseases.com/content/9/1/5
Page 4 of 7for gender, age, and treatment condition; see Table 3)
showed significant overall time effects for the d(T
gpA)
(c
2(3) = 9.389, p < 0.025), d(P
fpA) (c
2(3) = 9.070, p <
0.028), and d(G
h)( c
2(3) = 37.236, p < 0.001) lesions,
indicating levels of each decreased significantly after
smoking cessation. The d(T
gpA) and d(P
fpA) lesions
show relatively greater rebound at TQD+11 weeks com-
pared to the d(G
h) lesion (88% of baseline for d(T
gpA),
64% of baseline for d(P
fpA), vs 46% of baseline for d
(G
h). Indeed, the GEE models show that the value 11
weeks following TQD is not statistically different from
the baseline value for d(T
gpA), however those differ-
ences are significant for d(P
fpA) and d(G
h). We did not
see a significant association of lesion levels with age or
gender. In the case of the d(G
h) lesion, we observed a
statistically significant treatment group difference (c
2(1)
= 4.910, p < 0.027), wherein those in the treatment arm
had overall significantly higher d(G
h) levels (23.0 versus
18.1).
Discussion
The findings from this study indicate that cigarette
smoking appears to be related to oxidatively generated
DNA damage, and that smoking cessation may reduce
levels of oxidative damage between 30-50 percent in the
short term (11 weeks following cessation). This study
supports earlier findings [13,14] that the d(G
h)l e s i o ni s
associated with smoking, and also supports findings by
Nia and colleagues [15] which reported decreases in d
(G
h) after smoking cessation. This study also provides
preliminary evidence that smoking may also contribute
to formamide [d(P
fpA)] DNA lesions, while evidence for
a relationship between smoking and the thymine glycol
[d(T
gpA)] lesion was weaker. Carmella and colleagues
[25] proposed that sensitivity to changes in smoking (e.
g., cessation) within-subjects is a strong indicator of the
utility of a biomarker, as it allows individuals to serve as
their own controls, minimizing the potential role for
individual differences in DNA repair or toxicant meta-
bolism as possible explanations for observed variations.
By this standard, d(G
h) and d(P
fpA) may be promising
biomarkers for future evaluation.
We are unable to explain the slight increase in levels
of two biomarkers at the final measurement, despite
controlling for CO-confirmed abstinence and self-
reported cigarette use. One hypothesis is that these mar-
kers are sensitive to small exposures to cigarette smoke,
including exposure to secondhand smoke (which was
not measured) as well as other environmental expo-
sures/sources. Indeed, other research has noted expo-
sure to SHS as a potential source of oxidative damage in
nonsmokers, [17,18] so this remains a plausible explana-
tion. Alternatively, it may reflect the normal range of
variability in oxidative damage with an individual over
time.
A difficulty associated with assessing oxidative DNA
damage caused by a single mechanism, such as smoking,
is that a substantial level of damage is always present.
Further, other environmental and demographic factors,
particularly age, gender and diet, may influence damage
levels. The contribution of smoking to oxidative DNA
damage must be assessed by the incremental change
produced by the behavior relative to background levels.
A significant advantage of the present study was the
longitudinal assessment of DNA damage among a group
of smokers who participated in a smoking cessation
trial; with this design individuals served as their own
controls. However, this study also had weaknesses,
including a small sample size, examination of only three
DNA modifications, and lack of data regarding other
Table 3 Parameter estimates from GEE models for each modification (statistically significant beta weights highlighted
in bold)
d(T
gpA) d(P
fpA) dG
h
B SE Wald c
2
(df = 1)
p B SE Wald c
2
(df = 1)
p B SE Wald c
2
(df = 1)
p
Intercept 0.015 0.52 0.001 0.078 0.486 0.487 0.993 0.319 3.815 0.208 336.884 <0.001
Active Tx REF REF REF
Placebo 0.044 0.11 0.020 0.185 -0.193 0.132 2.139 0.085 -0.244 0.110 4.910 0.027
Female REF REF REF
Male 0.145 0.11 1.758 0.185 0.120 0.141 0.730 0.393 0.083 0.097 0.733 0.392
TQD - 4 weeks [baseline] REF REF REF
TQD [week 0] -0.398 0.22 3.170 0.075 -0.221 0.129 2.958 0.085 -0.434 0.094 21.303 <0.001
TQD + 4 weeks [week 4] -0.496 0.17 8.454 0.004 -0.546 0.191 8.196 0.004 -0.744 0.124 36.068 <0.001
TQD +11 [week 11] -0.147 0.24 0.387 0.534 -0.447 0.187 5.704 0.017 -0.765 0.202 14.299 <0.001
Age -0.001 0.008 0.020 0.889 0.004 0.009 0.229 0.632 -0.005 0.004 1.549 0.213
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appears to influence forms of oxidative stress beyond
oxidatively induced DNA damage, such as lipid peroxi-
dation [26]. Recent papers have used other approaches
and markers of oxidative stress related to cigarette
smoking in addition to d(G
h), including isoprostanes,
hydroxyeicosatetraenoic acid products (HETEs), and
advanced glycation end-products [27-29]. Future
research should look to examine the contribution of
smoking to oxidative stress in a broader context, includ-
ing additional markers, other sources of damage, and
individual DNA repair capacity.
O v e r a l l ,r e s u l t sf r o mt h i sa n a l y s i ss u g g e s tt h a tc i g a r -
ette smoking contributes to the burden of oxidative
DNA damage in smokers, but that the level of such
DNA modifications may be reduced by stopping smok-
ing. Future research may shed light on the broader array
of oxidative damage influenced by smoking, to provide
further insights into mechanisms underlying
carcinogenesis.
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